Diabetes Pro Quarterly - Spring 2022 - 17

82nd Scientific Sessions News
transition off of insulin injection therapy and organizing the
first meeting for families with neonatal diabetes to offer
knowledge and support for these families.
Anna Gloyn, DPhil, is the recipient of the
2022 Outstanding Scientific Achievement
Award, which recognizes research in diabetes
that demonstrates particular independence of
thought and originality. Dr. Gloyn is a leader
in efforts to discover the genetic basis of type 2 diabetes.
She uses human genetics as a tool to understand cellular
and molecular mechanisms for pancreatic β-cell failure in
diabetes and related conditions. Her efforts seek to improve
understanding of pancreatic islet cell dysfunction to advance
treatment options for patients.
Amy Hess-Fischl, MS, RDN, LDN, BCADM,
CDCES, is the recipient of the 2022
Outstanding Educator in Diabetes Award,
which recognizes a distinguished health
professional who has made outstanding
educational efforts in the field of diabetes. Ms. Fischl was
a co-author of the 2015 and 2020 consensus reports on
diabetes self-management education and support (DSMES)
in type 2 diabetes and was a co-author of the 2017 national
standards for DSMES and co-chair of the 2022 revision
of those standards. She is the creator of the In Transit
program at the University of Chicago, where she works with
transitioning youth with type 1 diabetes in a collaborative
care environment.
Hertzel C. Gerstein, MD, MSc, FRCPC,
is the recipient of the 2022 Outstanding
Achievement in Clinical Diabetes Research
Award, which recognizes exceptional
contributions in patient-oriented clinical
outcomes research that have had a significant impact on
diabetes prevention and treatment. Dr. Gerstein co-led
MICROHOPE (Microalbuminuria Cardiovascular Renal
Outcomes-Heart Outcomes Prevention Study), the first
cardiovascular trial with a large diabetes cohort, and his
discoveries related to ACE inhibitors, thiazolidinediones, and
insulin have been transformative in furthering understanding
of diabetes and cardiovascular outcomes.
Janet B. McGill, MD, MA, FACP, is the
recipient of the 2022 Outstanding Physician
Clinician in Diabetes Award, which is
presented to honor meritorious contributions to
diabetes clinical practice. Dr. McGill has been
an active clinical researcher in diabetes for more than 30
years and continues to test new therapies for diabetes and
novel approaches to type 1 and type 2 diabetes treatment.
Currently, she is a principal investigator (PI) or subinvestigator
on more than 10 clinical trials investigating new
treatments for diabetes and its complications.
Jane E.B. Reusch, MD, is the recipient of the
2022 Albert Renold Award, which is presented
to an individual whose career is distinguished
by outstanding achievements in the training
and mentorship of diabetes research scientists
and in the development of communities of scientists to
enhance diabetes research. Dr. Reusch has dedicated herself
to training the next generation of physician scientists and to
strengthening the clinical-translational workforce. At the core
of her world-class National Institutes of Health-, Veterans
Administration-, and ADA-funded translational diabetes
research program is the mission to recruit, train, and retain
new translational scientists for the diabetes workforce. She
has directly mentored more than 70 students, pre- and
postdoctoral fellows, and junior and senior faculty.
Jill Norris, MPH, PhD, is the recipient of the
2022 Kelly West Award for Outstanding
Achievement in Epidemiology, which
recognizes significant contributions to the
field of diabetes epidemiology. Dr. Norris'
research has focused on the relationship between genes and
environment in the development of autoimmune diseases and
metabolic disease. She was the PI of the Colorado site of the
IRAS (Insulin Resistance Atherosclerosis Study) Family Study,
and the Colorado site of the ADA-funded GENNID (Genetics
of NIDDM) study, the nutrition studies of DAISY (Diabetes
Autoimmunity Study in the Young) since 1996, and has been
a PI of SERA (Studies of the Etiology of RA). She has been a
co-investigator of the DAISY since 1993, the CEDAR (Celiac
Disease Autoimmunity Research) study since 1995, and a cochair
of the Diet Committee of the TEDDY (The Environmental
Determinants of Diabetes in the Young) Study since 2002.
DID YOU KNOW?
Education Recognition
Programs Finder
American Diabetes Association-recognized
diabetes self-management education and
support programs help your patients gain
the knowledge, skills, and confidence
they need to thrive with diabetes.
Visit www.diabetes.org/findaprogram
to find a recognized diabetes education
program near you.
professional.diabetes.org 17
http://www.diabetes.org/findaprogram http://professional.diabetes.org
Diabetes Pro Quarterly - Spring 2022

Table of Contents for the Digital Edition of Diabetes Pro Quarterly - Spring 2022
